Zenotech Laboratories Ltd
Submission of Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
RESULTS
▼ Concern Flagged
MEDIUM RISK
📅 Filed on BSE: 28 Jul 2026, 02:40 PM IST · BSE ID: 0abc5cb8-c439-4d18-8b8b-f14eeb768048
View Original BSE Filing (PDF)
💡
In Simple Terms
Zenotech Laboratories reported a net loss of Rs. 45.55 lakhs and approved their annual shareholder meeting date.
🤖 AI Summary
- Board approved Unaudited Standalone Financial Results for Q1 FY27, reporting Net Loss of Rs. 45.55 lakhs.
- Revenue from operations stood at Rs. 959.64 lakhs for the quarter ended June 30, 2026.
- Total expenses for the quarter were Rs. 1,164.86 lakhs, compared to Rs. 895.48 lakhs in Q1 FY26.
- The 37th Annual General Meeting is scheduled for September 25, 2026, at 10:30 A.M. IST.
- Basic and Diluted Loss Per Share for the quarter ended June 30, 2026, was Rs. (0.07).
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (Q1 FY27)
959.64 lakhs
11.08%
Profit/(Loss) for the period (Q1 FY27)
(45.55) lakhs
Not comparable — negative to positive shift.
Total Expenses (Q1 FY27)
1,164.86 lakhs
29.86%
Basic EPS (Q1 FY27)
(0.07)
Not comparable — negative to positive shift.
🏢 How This Affects the Company
The company reported a Net Loss of Rs. 45.55 lakhs for the quarter ended June 30, 2026, shifting from a profit in the comparable prior period. This includes a deferred tax expense of Rs. (14.52) lakhs for the quarter.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are requested to update their information with depositories or the Company's RTA to receive AGM notices and the Annual Report.
👤
Who Is Affected
All shareholders are affected by the financial results and the upcoming 37th Annual General Meeting on September 25, 2026. Paid-up equity share capital remains Rs. 6,103.06 lakhs.
🔍
Management Signal
Management approved the Q1 FY27 financial results and initiated the process for the 37th Annual General Meeting, indicating adherence to regulatory compliance and corporate governance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Release of the Notice of the 37th Annual General Meeting and Annual Report.
Outcome of the 37th Annual General Meeting on September 25, 2026.
Unaudited Financial Results for the quarter ending September 30, 2026.
MEDIUM RISK
The company reported a Net Loss for the quarter, indicating financial performance challenges.
💡 Investor Takeaway
Zenotech Laboratories reported a Net Loss of Rs. 45.55 lakhs for the quarter ended June 30, 2026. Revenue from operations was Rs. 959.64 lakhs. Total expenses increased to Rs. 1,164.86 lakhs from Rs. 895.48 lakhs in the prior year comparable quarter.
⚖️ Strengths & Concerns
⚠️ Concerns
- Zenotech Laboratories reported a Profit/(Loss) for the period of Rs. (45.55) lakhs for Q1 FY27, a decline from Rs. 98.96 lakhs in Q1 FY26.
- Basic and Diluted Earnings/(loss) per share for the quarter ended June 30, 2026, was Rs. (0.07), down from Rs. 0.16 in the prior comparable period.
📅 Company Track Record
Zenotech Laboratories reported a net loss of Rs. 107.21 lakhs for the financial year ended March 31, 2026, a decline from a prior profit of Rs. 561.29 lakhs, primarily influenced by a deferred tax charge of Rs. 477.18 lakhs.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Zenotech Laboratories' Net Profit/Loss for Q1 FY27?
Zenotech Laboratories reported a Net Loss of Rs. (45.55) lakhs for the quarter ended June 30, 2026.
What was the Revenue from operations for Zenotech Laboratories in Q1 FY27?
Revenue from operations for Zenotech Laboratories was Rs. 959.64 lakhs for the quarter ended June 30, 2026.
When is Zenotech Laboratories' 37th Annual General Meeting scheduled?
The 37th Annual General Meeting for Zenotech Laboratories is scheduled for Friday, September 25, 2026, at 10:30 A.M. IST.
What were the total expenses for Zenotech Laboratories in Q1 FY27?
Total expenses for Zenotech Laboratories in the quarter ended June 30, 2026, were Rs. 1,164.86 lakhs.
Questions based on this BSE filing only. For information purposes.